Lipoteichoic acid from Lactobacillus plantarum inhibits Pam2CSK4-induced IL-8 production in human intestinal epithelial cells

Molecular Immunology

Volumn 64, Issue 1, 2015, Pages 183-189

  Noh, Su Young ^a   Kang, Seok Seong ^a   Yun, Cheol Heui ^a   Han, Seung Hyun ^a  

^a Seoul National University   (South Korea)

Author keywords

Interleukin 8; Intestinal epithelial cells; Lactobacillus plantarum; Lipoteichoic acid; Pam2CSK4

Indexed keywords

CD14 ANTIGEN; DEXTRO ALANINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPID; LIPOTEICHOIC ACID; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; MITOGEN ACTIVATED PROTEIN KINASE P38; PAM2CSK4; STRESS ACTIVATED PROTEIN KINASE; SYNTHETIC PEPTIDE; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; ALANINE; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PAM2CSK4 LIPOPEPTIDE; PEPTIDOGLYCAN; TEICHOIC ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CACO 2 CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SAKEI; MACROPHAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS MUTANS; THIN LAYER CHROMATOGRAPHY; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECTS; INTESTINE CELL; METABOLISM; PHOSPHORYLATION;

BACTERIA (MICROORGANISMS); LACTOBACILLUS PLANTARUM; POSIBACTERIA;

ALANINE; CACO-2 CELLS; ENTEROCYTES; HUMANS; INTERLEUKIN-8; LACTOBACILLUS PLANTARUM; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDOGLYCAN; PHOSPHORYLATION; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2;

EID: 84920101548     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.11.014     Document Type: Article

References (41)

1. Ahn K.B., Jeon J.H., Baik J.E., Park O.J., Kang S.S., Yun C.H., Park J.H., Han S.H. Muramyl dipeptide potentiates staphylococcal lipoteichoic acid induction of cyclooxygenase-2 expression in macrophages. Microbes Inefect. 2014, 16:153-160.
2. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 2001, 46:27-43.
3. Baik J.E., Jang K.S., Kang S.S., Yun C.H., Lee K., Kim B.G., Kum K.Y., Han S.H. Calcium hydroxide inactivates lipoteichoic acid from Enterococcus faecalis through deacylation of the lipid moiety. J. Endod. 2011, 37:191-196.
4. Bermudez-Brito M., Munoz-Quezada S., Gomez-Llorente C., Matencio E., Bernal M.J., Romero F., Gil A. Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR activation. PLoS One 2012, 7:e43197.
5. Brestoff J.R., Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat. Immunol. 2013, 14:676-684.
6. Bron P.A., Tomita S., Mercenier A., Kleerebezem M. Cell surface-associated compounds of probiotic lactobacilli sustain the strain-specificity dogma. Curr. Opin. Microbiol. 2013, 16:262-269.
7. Corr S.C., Li Y., Riedel C.U., O'Toole P.W., Hill C., Gahan C.G. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7617-7621.
8. De Kimpe S.J., Kengatharan M., Thiemermann C., Vane J.R. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:10359-10363.
9. Fabretti F., Theilacker C., Baldassarri L., Kaczynski Z., Kropec A., Holst O., Huebner J. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect. Immun. 2006, 74:4164-4171.
10. Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect. Dis. 2002, 2:171-179.
11. Grangette C., Nutten S., Palumbo E., Morath S., Hermann C., Dewulf J., Pot B., Hartung T., Hols P., Mercenier A. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10321-10326.
12. Henderson A.J., Kumar A., Barnett B., Dow S.W., Ryan E.P. Consumption of rice bran increases mucosal immunoglobulin A concentrations and numbers of intestinal Lactobacillus spp. J. Med. Food. 2012, 15:469-475.
13. Hidalgo I.J., Raub T.J., Borchardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989, 96:736-749.
14. Hirano J., Yoshida T., Sugiyama T., Koide N., Mori I., Yokochi T. The effect of Lactobacillus rhamnosus on enterohemorrhagic Escherichia coli infection of human intestinal cells in vitro. Microbiol. Immunol. 2003, 47:405-409.
15. Hong S.W., Baik J.E., Kang S.S., Yun C.H., Seo D.G., Han S.H. Lipoteichoic acid of Streptococcus mutans interacts with Toll-like receptor 2 through the lipid moiety for induction of inflammatory mediators in murine macrophages. Mol. Immunol. 2014, 57:284-291.
16. Jang K.S., Baik J.E., Han S.H., Chung D.K., Kim B.G. Multi-spectrometric analyses of lipoteichoic acids isolated from Lactobacillus plantarum. Biochem. Biophys. Res. Commun. 2011, 407:823-830.
17. Kang J.Y., Nan X., Jin M.S., Youn S.J., Ryu Y.H., Mah S., Han S.H., Lee H., Paik S.G., Lee J.O. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009, 31:873-884.
18. Kim H.G., Kim N.R., Gim M.G., Lee J.M., Lee S.Y., Ko M.Y., Kim J.Y., Han S.H., Chung D.K. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-alpha production in THP-1 cells and endotoxin shock in mice. J. Immunol. 2008, 180:2553-2561.
19. Lebeer S., Claes I.J., Vanderleyden J. Anti-inflammatory potential of probiotics: lipoteichoic acid makes a difference. Trends Microbiol. 2012, 20:5-10.
20. Lee I.C., Tomita S., Kleerebezem M., Bron P.A. The quest for probiotic effector molecules--unraveling strain specificity at the molecular level. Pharmacol. Res. 2013, 69:61-74.
21. Macho Fernandez E., Valenti V., Rockel C., Hermann C., Pot B., Boneca I.G., Grangette C. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 2011, 60:1050-1059.
22. Mackie R.I., Sghir A., Gaskins H.R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 1999, 69:1035S-1045S.
23. Madsen K.L., Doyle J.S., Jewell L.D., Tavernini M.M., Fedorak R.N. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999, 116:1107-1114.
24. Matsumoto S., Hara T., Hori T., Mitsuyama K., Nagaoka M., Tomiyasu N., Suzuki A., Sata M. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 2005, 140:417-426.
25. Medvedev A.E., Henneke P., Schromm A., Lien E., Ingalls R., Fenton M.J., Golenbock D.T., Vogel S.N. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J. Immunol. 2001, 167:2257-2267.
26. Meunier V., Bourrie M., Berger Y., Fabre G. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol. Toxicol. 1995, 11:187-194.
27. Moorthy G., Murali M.R., Niranjali Devaraj S. Lactobacilli inhibit Shigella dysenteriae 1 induced pro-inflammatory response and cytotoxicity in host cells via impediment of Shigella-host interactions. Dig. Liver Dis. 2010, 42:33-39.
28. Morath S., Geyer A., Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 2001, 193:393-397.
29. Morath S., Stadelmaier A., Geyer A., Schmidt R.R., Hartung T. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 2002, 195:1635-1640.
30. O'Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006, 7:688-693.
31. Perea Velez M., Verhoeven T.L., Draing C., Von Aulock S., Pfitzenmaier M., Geyer A., Lambrichts I., Grangette C., Pot B., Vanderleyden J., De Keersmaecker S.C. Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG. Appl. Environ. Microbiol. 2007, 73:3595-3604.
32. Philpott D.J., Girardin S.E., Sansonetti P.J. Innate immune responses of epithelial cells following infection with bacterial pathogens. Curr. Opin. Immunol. 2001, 13:410-416.
33. Ryu Y.H., Baik J.E., Yang J.S., Kang S.S., Im J., Yun C.H., Kim D.W., Lee K., Chung D.K., Ju H.R., Han S.H. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Int. Immunopharmacol. 2009, 9:127-133.
34. Sambuy Y., De Angelis I., Ranaldi G., Scarino M.L., Stammati A., Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol. 2005, 21:1-26.
35. Sheil B., Shanahan F., O'Mahony L. Probiotic effects on inflammatory bowel disease. J. Nutr. 2007, 137. 819S-24S.
36. Simonet W.S., Hughes T.M., Nguyen H.Q., Trebasky L.D., Danilenko D.M., Medlock E.S. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J. Clin. Invest. 1994, 94:1310-1319.
37. Singer M., Sansonetti P.J. IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. J. Immunol. 2004, 173:4197-4206.
38. Tien M.T., Girardin S.E., Regnault B., Le Bourhis L., Dillies M.A., Coppee J.Y., Bourdet-Sicard R., Sansonetti P.J., Pedron T. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J. Immunol. 2006, 176:1228-1237.
39. Wang J.E., Dahle M.K., McDonald M., Foster S.J., Aasen A.O., Thiemermann C. Peptidoglycan and lipoteichoic acid in gram-positive bacterial sepsis: receptors, signal transduction, biological effects, and synergism. Shock 2003, 20:402-414.
40. Wicken A.J., Knox K.W. Lipoteichoic acids: a new class of bacterial antigen. Science 1975, 187:1161-1167.
41. Wright H.L., Moots R.J., Bucknall R.C., Edwards S.W. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 2010, 49:1618-1631.